PARNELL PHARMACEUTICALS, INC. – Trademark Portfolio
Entity Type: 03
PARNELL PHARMACEUTICALS, INC. holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 16 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include Y S, PRETZ, PARNELL, FEMINEASE, and MOUTH KOTE. The owner is based in SAN RAFAEL, CA.
3070 Kerner Blvd., Ste. A
SAN RAFAEL, CA 94901
Showing of trademarks Trademarks
Trademark Classifications
PARNELL PHARMACEUTICALS, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does PARNELL PHARMACEUTICALS, INC. have?
PARNELL PHARMACEUTICALS, INC. has 17 U.S. trademarks filed with the USPTO. Of these, 7 registered, 3 abandoned, 7 cancelled.
What trademark classes does PARNELL PHARMACEUTICALS, INC. file in?
PARNELL PHARMACEUTICALS, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are PARNELL PHARMACEUTICALS, INC.'s most well-known trademarks?
PARNELL PHARMACEUTICALS, INC.'s registered trademark portfolio includes well-known marks such as Y S, PRETZ, PARNELL, FEMINEASE, and MOUTH KOTE. These are among 7 currently registered trademarks in the portfolio.
What is PARNELL PHARMACEUTICALS, INC.'s trademark registration success rate?
PARNELL PHARMACEUTICALS, INC. has a 41% trademark registration rate, with 7 out of 17 resolved applications resulting in successful registration. Currently, 0 applications are pending review.